Phase 1 Vaccine Preventable Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

vaccine preventable diseasesHerpes ZosterShingles

Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823

Recruiting

Phase 1

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

vaccine preventable diseasesHerpes Zoster

CHA Vaccine Institute Co., Ltd.32 enrolled2 locationsNCT06137755